X

Xenon Pharmaceuticals
D

XENE

39.690
USD
0.41
(1.04%)
مغلق
حجم التداول
5,216
الربح لكل سهم
-4
العائد الربحي
-
P/E
-14
حجم السوق
3,025,949,803
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    N
    NBIX
    4.630
    (3.99%)
    120.710 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    X
    XNCR
    -0.030
    (-0.19%)
    15.740 USD
    المزيد
الأخبار
المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.